News

The BenchMark XT instrument, the HER2 Dual ISH assay, is now approved for use on both Ventana BenchMark advanced staining platforms available in the US. The HER2 Dual

Inhibition of ALDH2 activity, a key enzyme in ethanol metabolism, through the silencing of ALDH2, results in the build-up of acetaldehyde, which causes adverse physiological effects that cause

The new plant, which will produce Ensure and Glucerna for the North America market, is expected to become operational in late 2013. The new manufacturing facility will specialize

Ultresa (Pancrelipase) delayed release capsules are indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis (CF) or other conditions. Viokace (Pancrelipase) tablets are indicated for

Fabrazyme is approved for treatment of Fabry disease, an inherited condition that is characterized by excessive accumulation of the lipid GL-3 in various organs and tissues. Patients in

The partnership will allow Cheminnova to gain significant stake in exchange for the intellectual property rights for RNL’s product range for some markets and the manufacturing rights for

Acceliant, a comprehensive clinical data management platform, will support Phase I-IV trials and post-marketing studies for all therapeutic areas and medical devices. The solution supports a clinical trial

Omkar Speciality manufactures speciality chemicals such as selenium compounds, iodine compounds, molybdenum compounds and pharma intermediates including potassium iodate, bismuth ammonium citrate, bromoform. The company has four units

According to the agreement, the company has agreed to issue an aggregate of 200,000 shares of its newly designated shares of Series C preferred stock in exchange for